Saturday 17 October 2026
Export QDEL’s income statement to Excel — free account
QuidelOrtho Corporation
QDEL Healthcare Medical Devices
QuidelOrtho Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 1.89% from fiscal 2024. In the quarter to June 2026, revenue grew 2.77%, EPS grew 63.9%, free cash flow fell 61.5% and total debt rose 10.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
12.94
0.97
−6.97%
Follow QDEL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 6.76 | 8.04 | 9.34 | 42.15 | 24.66 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 3 | 4 | 3 | 6 | 7 | 5 | 7 | 3 | 4 |
P/S ratio |
0.71 | 1.08 | 1.67 | 1.48 | 3.35 | 4.55 | 5.73 | 3.55 | 5.40 | 3.56 |
Altman Z-Score |
0.11 | 0.02 | 1.66 | 1.85 | 10.24 | 12.41 | 6.50 | 4.12 | 1.81 | 3.27 |
P/FCF ratio |
0.00 | 0.00 | 70.82 | 6.49 | 11.08 | 13.40 | 28.69 | 17.79 | 153.10 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(0.56) | (0.85) | 2.78 | 3.19 | 11.78 | 10.88 | 3.53 | 2.50 | 1.79 | 4.25 |
Beneish M-Score |
(3.12) | (4.30) | (2.93) | (2.13) | (2.68) | 0.31 | (2.22) | (2.34) | (1.09) | (2.44) |
P/Operating CF |
14.68 | 47.00 | 62.09 | 28.50 | 17.68 | 17.23 | 64.24 | 42.92 | 133.52 | 41.09 |
P/B ratio |
1.01 | 1.00 | 1.00 | 0.98 | 2.95 | 5.68 | 5.48 | 4.36 | 6.60 | 3.40 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 3.80 | 8.66 | 41.05 | 0.00 | 0.00 | 7.66 |
EV/Sales |
1.62 | 1.93 | 2.41 | 2.18 | 2.86 | 4.32 | 5.85 | 3.58 | 6.70 | 3.43 |
EV/EBITDA |
19.76 | 17.07 | 12.14 | 6.32 | 5.06 | 6.48 | 20.82 | 11.98 | 38.01 | 27.13 |
EV/Operating CF |
41.98 | 64.80 | 25.84 | 8.04 | 6.02 | 11.41 | 23.28 | 13.72 | 67.13 | 55.67 |
EV/FCF |
(52.95) | (52.11) | 102.70 | 9.57 | 9.47 | 12.73 | 29.30 | 17.95 | 190.01 | (1,307.70) |
Quick Ratio |
0.61 | 0.38 | 0.56 | 0.79 | 3.73 | 2.93 | 1.17 | 0.64 | 0.80 | 5.79 |
Current Ratio |
1.50 | 1.22 | 1.57 | 1.56 | 4.45 | 3.39 | 1.77 | 1.21 | 2.58 | 6.71 |
Net Debt/EBITDA |
11.10 | 7.57 | 3.77 | 2.03 | (0.86) | (0.34) | 0.43 | 0.41 | 7.38 | (1.04) |
Debt/Assets |
45.94% | 38.66% | 28.20% | 29.79% | 0.03% | 6.04% | 12.95% | 13.29% | 42.50% | 37.18% |
Debt/Equity |
1.38 | 0.83 | 0.48 | 0.53 | 0.00 | 0.08 | 0.21 | 0.25 | 1.75 | 0.72 |
Asset Turnover |
0.45 | 0.37 | 0.34 | 0.58 | 0.79 | 1.19 | 0.62 | 0.60 | 0.42 | 0.48 |
Operating CF/Net income |
(0.09) | (0.04) | (27.74) | 1.61 | 1.14 | 0.78 | 1.84 | 1.84 | (3.39) | (0.86) |
Capex/Depreciation |
(0.16) | (0.08) | (0.46) | (0.50) | (5.56) | (1.33) | (0.47) | (0.53) | (0.44) | (0.42) |
Interest Coverage |
(5.18) | (11.99) | 0.94 | 11.15 | 156.21 | 124.74 | 6.27 | 3.95 | 0.54 | (0.36) |
| (46.15%) | (51.36%) | (0.20%) | 15.99% | 43.17% | 85.63% | 14.80% | 22.73% | (3.82%) | (6.59%) | |
| (18.56%) | (27.38%) | (0.12%) | 9.72% | 32.74% | 58.25% | 8.49% | 8.52% | (1.23%) | (3.47%) | |
ROIC |
(13.05%) | (22.83%) | 1.20% | 7.30% | 51.40% | 69.34% | 9.27% | 12.26% | 1.01% | (1.58%) |
Return on Tangible Assets |
(61.53%) | (128.23%) | (0.53%) | 28.77% | 48.04% | 88.47% | 41.41% | 68.97% | (3.09%) | (5.69%) |
Average Days of Receivables |
55.75 | 37.04 | 36.93 | 50.73 | 81.23 | 109.32 | 64.48 | 41.01 | 88.11 | 47.61 |
Research and Development Expense of Revenue |
6.82% | 7.86% | 8.17% | 5.75% | 5.63% | 5.07% | 9.83% | 9.89% | 12.11% | 20.18% |
Selling, General and Administrative Expense of Revenue |
27.33% | 27.55% | 25.46% | 19.01% | 14.11% | 10.87% | 30.64% | 29.47% | 34.72% | 40.08% |
Intangible Assets out of Total Assets |
0.44 | 0.53 | 0.63 | 0.63 | 0.18 | 0.25 | 0.53 | 0.64 | 0.58 | 0.29 |
Share Based Compensation of Revenue |
1.68% | 1.51% | 1.72% | 1.48% | 1.50% | 1.26% | 2.48% | 2.24% | 3.26% | 4.17% |
Graham Net Nets |
(1.24) | (0.74) | (0.45) | (0.49) | 0.17 | 0.08 | (0.04) | (0.10) | (0.25) | 0.06 |
Graham Number |
0.00 | 0.00 | 0.00 | 156.81 | 131.62 | 117.03 | 23.42 | 22.34 | 0.00 | 0.00 |
Earnings Yield |
(58.33%) | (67.97%) | (0.21%) | 14.80% | 12.45% | 10.70% | 2.37% | 4.06% | (0.52%) | (2.06%) |
Free Cash Flow Yield |
(4.31%) | (3.45%) | 1.41% | 15.41% | 9.02% | 7.46% | 3.49% | 5.62% | 0.65% | (0.07%) |
Revenue per Share |
40.27 | 41.41 | 44.88 | 57.50 | 40.35 | 39.47 | 13.09 | 13.75 | 8.23 | 5.86 |
Operating CF per Share |
1.55 | 1.24 | 4.19 | 15.59 | 19.14 | 14.96 | 3.29 | 3.59 | 0.82 | 0.36 |
Capex per Share |
(2.78) | (2.76) | (3.13) | (2.48) | (6.95) | (1.54) | (0.67) | (0.83) | (0.52) | (0.36) |
Free Cash Flow per Share |
(1.22) | (1.53) | 1.06 | 13.11 | 12.19 | 13.42 | 2.63 | 2.75 | 0.30 | 0.00 |
Cash per Share |
2.50 | 1.46 | 2.50 | 6.07 | 19.68 | 11.64 | 1.29 | 1.15 | 1.07 | 5.18 |
Shareholders Equity per Share |
28.33 | 44.41 | 74.94 | 86.88 | 45.83 | 31.66 | 13.70 | 11.20 | 6.73 | 6.13 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
28.33 | 44.41 | 74.94 | 86.88 | 45.83 | 31.66 | 13.70 | 11.20 | 6.73 | 6.13 |
Free Cash Flow |
(83.00) | (102.80) | 70.90 | 744.40 | 513.10 | 564.80 | 107.26 | 104.66 | 10.20 | (0.09) |
Working Capital |
481.20 | 220.10 | 476.70 | 568.10 | 1,116.80 | 805.44 | 96.34 | 33.66 | 202.88 | 191.78 |
Capital Expenditures |
(188.20) | (185.80) | (209.30) | (140.90) | (292.80) | (64.90) | (27.23) | (31.69) | (17.51) | (11.91) |
Net Current Asset Value |
(2,401.50) | (2,220.20) | (2,246.70) | (2,346.10) | 939.30 | 603.94 | (128.82) | (187.39) | (376.92) | 37.77 |
EV/EBIT |
0.00 | 0.00 | 52.04 | 8.44 | 5.36 | 6.78 | 33.77 | 19.51 | 194.74 | 0.00 |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.04 | 0.17 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 35.89 | 5.72 | 6.27 | 7.13 | 33.07 | 19.34 | 156.91 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.84 | 1.65 | 0.32 | 0.21 | 0.15 | 0.44 | 0.72 | 0.81 | 0.64 | 0.56 |
Cash ROIC |
(1.75%) | (1.85%) | 0.93% | 9.40% | 18.60% | 29.18% | 14.68% | 18.15% | 1.54% | (0.02%) |
Accounts Receivable Turnover |
7.81 | 9.50 | 7.92 | 7.85 | 3.88 | 5.61 | 6.98 | 8.31 | 6.04 | 8.83 |
Accounts Payable Turnover |
5.54 | 5.53 | 5.19 | 6.91 | 4.48 | 5.40 | 8.25 | 7.88 | 5.61 | 6.46 |
Inventory Turnover |
2.62 | 2.69 | 2.72 | 3.68 | 2.69 | 3.55 | 3.41 | 3.07 | 2.61 | 3.05 |
Average Days of Payables |
70.04 | 60.00 | 71.70 | 77.76 | 88.15 | 103.16 | 45.52 | 44.48 | 81.88 | 73.33 |
Days of Inventory on Hand |
144.80 | 130.18 | 140.53 | 143.85 | 172.64 | 136.01 | 99.03 | 119.05 | 201.34 | 119.02 |
Average Receivables |
349.70 | 292.85 | 378.60 | 415.95 | 437.84 | 296.09 | 76.59 | 62.86 | 46.02 | 21.69 |
Average Payables |
262.70 | 270.40 | 289.05 | 192.40 | 93.91 | 56.51 | 25.94 | 26.23 | 21.66 | 12.36 |
Average Inventory |
555.65 | 555.75 | 550.95 | 361.45 | 156.30 | 85.94 | 62.73 | 67.23 | 46.56 | 26.22 |
Average Assets |
6,096.45 | 7,493.35 | 8,709.45 | 5,643.10 | 2,150.78 | 1,391.02 | 858.62 | 870.81 | 661.75 | 397.38 |
Average Common Equity |
2,452.50 | 3,995.20 | 4,970.25 | 3,432.00 | 1,631.05 | 946.26 | 492.70 | 326.34 | 213.87 | 209.65 |
Columns are period end dates